Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines

International Immunology

Volumn 18, Issue 12, 2006, Pages 1801-1813

  Lau, Yuk Fai ^a   Deliyannis, Georgia ^a,b   Zeng, Weiguang ^a   Mansell, Ashley ^c   Jackson, David C ^a,b   Brown, Lorena E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VacTX Pty Ltd   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; GAMMA INTERFERON; INFLUENZA VACCINE; LIPOPEPTIDE; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG SCREENING; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS; INNATE IMMUNITY; LIPID ANALYSIS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RECEPTOR BINDING; SINGLE DRUG DOSE;

AMINO ACID SEQUENCE; ANIMALS; BIOMIMETICS; FEMALE; HUMANS; IMMUNITY, NATURAL; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIPOPROTEINS; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; REASSORTANT VIRUSES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33845352530     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl114     Document Type: Article

References (51)

1. Maassab, H. F., Cox, N. J., Murphy, B. R. and Kendal, A. P. 1977. Biological, genetic and biochemical characterization of a coldadapted recombinant A/Victoria/3/75 virus and its evaluation in volunteers. Dev. Biol. Stand. 39:25.
2. Polezhaev, F. I., Garmashova, L. M., Polyakov, Y. M., Golubev, D. B. and Aleksandrova, G. I. 1978. Conditions for production of thermosensitive attenuated influenza virus recombinants. Acta Virol. 22:263.
3. Deliyannis, G., Jackson, D. C., Ede, N. J. et al. 2002. Induction of long-term memory CD8(+) T cells for recall of viral clearing responses against influenza virus. J. Virol. 76:4212.
4. Sun, J. C. and Bevan, M. J. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339.
5. Shedlock, D. J. and Shen, H. 2003. Requirement for CD4 T cell help in generating functional CD8 Tcell memory. Science 300:337.
6. Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G. and Schoenberger, S. P. 2003. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852.
7. Zeng, W., Jackson, D. C., Murray, J., Rose, K. and Brown, L. E. 2000. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens. Vaccine 18:1031.
8. Zeng, W., Ghosh, S., Lau, Y. F., Brown, L. E. and Jackson, D. C. 2002. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines. J. Immunol. 169:4905.
9. Jackson, D. C., Lau, Y. F., Le, T. et al. 2004. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. Proc. Natl Acad. Sci. USA 101:15440.
10. BenMohamed, L., Krishnan, R., Auge, C., Primus, J. F. and Diamond, D. J. 2002. Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses. Immunology 106:113.
11. Brown, L. E. and Jackson, D. C. 2005. Lipid-based self-adjuvanting vaccines. Curr. Drug Delivery 2:383.
12. BenMohamed, L., Belkaid, Y., Loing, E., Brahimi, K., Gras-Masse, H. and Druilhe, P. 2002. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur. J. Immunol. 32:2274.
13. Loing, E., Andrieu, M., Thiam, K. et al. 2000. Extension of HLAA*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells. J. Immunol. 164:900.
14. Chua, B. Y., Healy, A., Cameron, P. U. et al. 2003. Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus. Immunol. Cell Biol. 81:67.
15. Zhu, X., Ramos, T. V., Gras-Masse, H., Kaplan, B. E. and BenMohamed, L. 2004. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity. Eur. J. Immunol. 34:3102.
16. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
17. Janeway, C. A. Jr and Medzhitov, R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197.
18. Hertz, C. J., Kiertscher, S. M., Godowski, P. J. et al. 2001. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166:2444.
19. Aliprantis, A. O., Yang, R. B., Mark, M. R. et al. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736.
20. Brightbill, H. D., Libraty, D. H., Krutzik, S. R. et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732.
21. Lien, E., Sellati, T. J., Yoshimura, A. et al. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419.
22. Bodmer, H. C., Pemberton, R. M., Rothbard, J. B. and Askonas, B. A. 1988. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Cell 52:253.
23. Jackson, D. C., Drummer, H. E. and Brown, L. E. 1994. Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus. Virology 198:613.
24. Jackson, D. C., Fitzmaurice, C. J., Brown, L. E. and Zeng, W. 1999. Preparation and properties of totally synthetic immunogens. Vaccine 18:355.
25. Zal, T., Volkmann, A. and Stockinger, B. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180:2089.
26. Tannock, G. A., Paul, J. A. and Barry, R. D. 1984. Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/ AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect. Immun. 43:457.
27. Winzler, C., Rovere, P., Rescigno, M. et al. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent longterm cultures. J. Exp. Med. 185:317.
28. Ozato, K., Mayer, N. and Sachs, D. H. 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124:533.
29. Brown, L. E., Murray, J. M., White, D. O. and Jackson, D. C. 1990. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Arch. Virol. 114:1.
30. Bowie, A. and O'Neill, L. A. 2000. The interleukin-1 receptor/Toll-like receptor superfamily: Signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 67:508.
31. Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G. et al. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78.
32. Wysocka, M., Kubin, M., Vieira, L. Q. et al. 1995. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.
33. Jackson, D. C., Tang, X. L., Brown, L. E., Murray, J. M., White, D. O. and Tregear, G. W. 1986. Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1. Virology 155:625.
34. Coles, R. M., Mueller, S. N., Heath, W. R., Carbone, F. R. and Brooks, A. G. 2002. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 168:834.
35. Bendelac, A. and Medzhitov, R. 2002. Adjuvants of immunity: Harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 195:F19.
36. Poltorak, A., He, X., Smirnova, I. et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085.
37. Curtsinger, J. M., Schmidt, C. S., Mondino, A. et al. 1999. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J. Immunol. 162:3256.
38. Deres, K., Schild, H., Wiesmuller, K. H., Jung, G. and Rammensee, H. G. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
39. Martinon, F., Gras-Masse, H., Boutillon, C. et al. 1992. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein. J. Immunol. 149:3416.
40. Takeuchi, O., Kaufmann, A., Grote, K. et al. 2000. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164:554.
41. Muhlradt, P. F., Kiess, M., Meyer, H., Sussmuth, R. and Jung, G. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951.
42. Ozinsky, A., Underhill, D. M., Fontenot, J. D. et al. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl Acad. Sci. USA 97:13766.
43. Takeuchi, O., Kawai, T., Muhlradt, P. F. et al. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13:933.
44. Takeuchi, O., Sato, S., Horiuchi, T. et al. 2002. Cutting edge: Role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10.
45. Reschner, A., Moretta, A., Landmann, R., Heberer, M., Spagnoli, G. C. and Padovan, E. 2003. The ester-bonded palmitoyl side chains of Pam3CysSerLys4 lipopeptide account for its powerful adjuvanticity to HLA class I-restricted CD8+ T lymphocytes. Eur. J. Immunol. 33:2044.
46. Schwarz, K., Storni, T., Manolova, V. et al. 2003. Role of Toll-like receptors in costimulating cytotoxic T cell responses. Eur. J. Immunol. 33:1465.
47. Schjetne, K. W., Thompson, K. M., Nilsen, N. et al. 2003. Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. J. Immunol. 171:32.
48. Birchler, T., Seibl, R., Buchner, K. et al. 2001. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur. J. Immunol. 31:3131.
49. Hertz, C. J., Wu, Q., Porter, E. M. et al. 2003. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J. Immunol. 171:6820.
50. Yang, D., Chertov, O., Bykovskaia, S. N. et al. 1999. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286:525.
51. Morrison, G. M., Davidson, D. J. and Dorin, J. R. 1999. A novel mouse beta defensin, Defb2, which is upregulated in the airways by lipopolysaccharide. FEBS Lett 442:112.